Skip to main content
. 2025;26(6):2025–2034. doi: 10.31557/APJCP.2025.26.6.2025

Table 1.

Demographic and Clinical Characteristics of the Brain Metastases Patients According to WBRT Treatment Admitted to the Dharmais National Cancer

Treated using WBRT No Yes Total P-value
n (%) 53 (35.8) 95 (64.2) 148 (100.0)
Sex, n (%)
Male 16 (30.2) 39 (41.1) 55 (37.2)
Female 37 (69.8) 56 (58.9) 93 (62.8) 0.19
Age group, n (%)
<40 6 (11.3) 13 (13.7) 19 (12.8)
40-50 14 (26.4) 26 (27.4) 40 (27.0)
50+ 33 (62.3) 56 (58.9) 89 (60.1) 0.90
Educational Background, n (%)
Secondary or below 9 (17.0) 21 (22.1) 30 (20.3)
High School/diploma 34 (64.2) 54 (56.8) 88 (59.5)
Post Graduated 10 (18.9) 20 (21.1) 30 (20.3) 0.66
Nutritional status, n (%)
Normal 30 (57.7) 43 (45.7) 73 (50.0)
Overweight 9 (17.3) 26 (27.7) 35 (24.0)
Underweight 13 (25.0) 25 (26.6) 38 (26.0) 0.29
Type of primary cancer, n (%)
Breast Cancer 22 (41.5) 30 (31.9) 52 (35.4)
Lung Cancer 22 (41.5) 50 (53.2) 72 (49.0)
Others 9 (17.0) 14 (14.9) 23 (15.6) 0.38
Multiple or Solitary metastases, n (%)
Multiple 36 (69.2) 64 (68.1) 100 (68.5)
Solitary 16 (30.8) 30 (31.9) 46 (31.5) 0.89
Location at supratentorial, n (%)
No 11 (20.8) 10 (10.6) 21 (14.3)
Yes 42 (79.2) 84 (89.4) 126 (85.7) 0.09
Location at infratentorial, n (%)
No 23 (43.4) 47 (50.0) 70 (47.6)
Yes 30 (56.6) 47 (50.0) 77 (52.4) 0.44
Extracranial metastases to lung, n (%)
No 42 (79.2) 70 (73.7) 112 (75.7)
Yes 11 (20.8) 25 (26.3) 36 (24.3) 0.45
Extracranial metastasis to liver, n (%)
No 40 (76.9) 68 (71.6) 108 (73.5)
Yes 12 (23.1) 27 (28.4) 39 (26.5) 0.48
Extracranial metastasis to bone, n (%)
No 26 (49.1) 54 (56.8) 80 (54.1)
Yes 27 (50.9) 41 (43.2) 68 (45.9) 0.36
Other extracranial metastases, n (%)
No 49 (92.5) 88 (92.6) 137 (92.6)
Yes 4 (7.5) 7 (7.4) 11 (7.4) 0.97
Brain Surgery, n (%)
No 39 (73.6) 66 (69.5) 105 (70.9)
Yes 14 (26.4) 29 (30.5) 43 (29.1) 0.60